PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Clinical trial NCT06721689 · RECRUITING

Trial details

NCT number: NCT06721689
Sponsor: Theodore Laetsch
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Solid Tumors Relapsed Solid Tumors Relapsed Neuroblastoma Refractory Neuroblastoma Relapsed Rhabdomyosarcoma Refractory Rhabdomyosarcoma

Start date: 2025-03-23
Primary completion: 2030-04-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.